Multivariate Statistics and Machine Learning for Quality Control of Dried Ocimum Products
Project Number5F31AT012139-02
Former Number1F31AT012139-01
Contact PI/Project LeaderABRAHAM, EVELYN
Awardee OrganizationPENNSYLVANIA STATE UNIVERSITY, THE
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
As the demand for medicinal plant products increases, so does the possibility of adulteration. Authentication of
botanicals is complicated due to the immense quantity of molecular markers, including genetic loci and small
molecules, within plant systems. This complexity also hinders identification of bioactive compounds responsible
for the desired medicinal outputs. However, the improved accessibility of advanced statistical processing allows
harnessing of these species-specific markers for sample identification and biomarker discovery. The overall
hypothesis of this study is that multivariate and machine learning models will streamline multifaceted
natural product investigations. Aim 1 applies multivariate statistics to genetic barcoding and high-resolution
metabolomics data to develop authentication schemes, with Ocimum spp. (basil) as a model system. Random
Forest and Partial Least Squares models are built using greenhouse grown, authenticated basil plants and used
to predict the identity of consumer available products. Aim 2 uses the same statistical approaches to identify
compounds responsible for both basil’s cytotoxic and antimicrobial properties. Developed models will also be
used to predict dual-action bioactivity status of unknown samples. Models with the combined ability to identify
bioactive compounds and samples will be recommended for future studies to improve compound discovery and
classification of bioactive plants. The collection of data, development of statistical models, and professional
development activities described herein will result in the development of a well-rounded, independent
researcher.
Public Health Relevance Statement
PROJECT NARRATIVE:
With increased market demand for medicinal plant products comes a greater risk for adulteration of botanicals,
posing a large health risk to consumers. The innate complexity of herbal products makes authentication and
identification of bioactive compounds challenging. Thus, this proposal aims to combine advanced metabolomic
(UPLC-HRMS), DNA barcoding, and bioactivity data with multivariate statistical models and machine learning
algorithms for improved authentication schemes and bioactive compound discovery, using Ocimum (basil) as a
model species, to develop novel approaches with application to a range of botanical products.
National Center for Complementary and Integrative Health
CFDA Code
213
DUNS Number
003403953
UEI
NPM2J7MSCF61
Project Start Date
01-May-2023
Project End Date
30-April-2025
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$41,427
Direct Costs
$41,427
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Center for Complementary and Integrative Health
$41,427
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F31AT012139-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F31AT012139-02
Patents
No Patents information available for 5F31AT012139-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F31AT012139-02
Clinical Studies
No Clinical Studies information available for 5F31AT012139-02
News and More
Related News Releases
No news release information available for 5F31AT012139-02
History
No Historical information available for 5F31AT012139-02
Similar Projects
No Similar Projects information available for 5F31AT012139-02